Ct Mason Has Decreased Its Stake in Procter & Gamble Co. (PG) by $523,250; Teva Pharmaceutical Inds LTD (Call) (TEVA) Stake Has Raised by Equitec Specialists Llc

February 15, 2018 - By Darrin Black

Equitec Specialists Llc increased its stake in Teva Pharmaceutical Inds Ltd (Call) (TEVA) by 110.71% based on its latest 2017Q3 regulatory filing with the SEC. Equitec Specialists Llc bought 18,600 shares as the company’s stock declined 15.11% while stock markets rallied. The institutional investor held 35,400 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $623,000, up from 16,800 at the end of the previous reported quarter. Equitec Specialists Llc who had been investing in Teva Pharmaceutical Inds Ltd (Call) for a number of months, seems to be bullish on the $19.64B market cap company. The stock increased 4.37% or $0.81 during the last trading session, reaching $19.33. About 16.91M shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since February 15, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

Ct Mason decreased its stake in Procter & Gamble Co. (PG) by 27.98% based on its latest 2017Q3 regulatory filing with the SEC. Ct Mason sold 5,750 shares as the company’s stock declined 5.32% while stock markets rallied. The institutional investor held 14,800 shares of the package goods and cosmetics company at the end of 2017Q3, valued at $1.35 million, down from 20,550 at the end of the previous reported quarter. Ct Mason who had been investing in Procter & Gamble Co. for a number of months, seems to be less bullish one the $203.39 billion market cap company. The stock decreased 1.01% or $0.82 during the last trading session, reaching $80.68. About 9.41 million shares traded or 12.20% up from the average. The Procter & Gamble Company (NYSE:PG) has risen 7.54% since February 15, 2017 and is uptrending. It has underperformed by 9.16% the S&P500.

Among 35 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 8 Sell and 18 Hold. Therefore 26% are positive. Teva Pharma had 145 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Underperform” rating by Credit Suisse on Monday, November 6. The firm earned “Market Perform” rating on Friday, August 4 by Bernstein. Oppenheimer upgraded the stock to “Outperform” rating in Friday, September 2 report. On Friday, August 4 the stock rating was downgraded by Cowen & Co to “Market Perform”. On Thursday, August 3 the stock rating was maintained by Cantor Fitzgerald with “Hold”. Maxim Group maintained the stock with “Hold” rating in Monday, February 13 report. RBC Capital Markets maintained the shares of TEVA in report on Tuesday, January 30 with “Sell” rating. The stock has “Outperform” rating by Maxim Group on Thursday, March 30. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) earned “Buy” rating by Jefferies on Thursday, July 14. The firm has “Hold” rating given on Wednesday, January 31 by Guggenheim.

Equitec Specialists Llc, which manages about $649.83M US Long portfolio, decreased its stake in Mannkind Corp (Put) by 207,600 shares to 11,800 shares, valued at $26,000 in 2017Q3, according to the filing. It also reduced its holding in Welltower Inc by 123,407 shares in the quarter, leaving it with 212,712 shares, and cut its stake in Epr Pptys.

Among 24 analysts covering Proctor & Gamble (NYSE:PG), 12 have Buy rating, 0 Sell and 12 Hold. Therefore 50% are positive. Proctor & Gamble had 77 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of The Procter & Gamble Company (NYSE:PG) has “Buy” rating given on Wednesday, October 26 by B. Riley & Co. The stock of The Procter & Gamble Company (NYSE:PG) has “Buy” rating given on Tuesday, September 8 by Suntrust Robinson. As per Wednesday, January 24, the company rating was maintained by JP Morgan. The rating was upgraded by Stifel Nicolaus to “Buy” on Tuesday, January 19. On Wednesday, October 12 the stock rating was upgraded by Argus Research to “Buy”. The stock of The Procter & Gamble Company (NYSE:PG) has “Buy” rating given on Monday, August 15 by B. Riley & Co. The rating was maintained by RBC Capital Markets with “Hold” on Friday, June 30. Jefferies maintained The Procter & Gamble Company (NYSE:PG) rating on Tuesday, May 30. Jefferies has “Buy” rating and $9800 target. Deutsche Bank maintained it with “Buy” rating and $90 target in Friday, July 31 report. The firm has “Equal Weight” rating by Morgan Stanley given on Tuesday, September 1.

Since August 15, 2017, it had 0 buys, and 3 selling transactions for $3.16 million activity. The insider Majoras Deborah P sold $231,206. Fish Kathleen B sold $144,688 worth of The Procter & Gamble Company (NYSE:PG) on Tuesday, August 15. Shares for $77,130 were sold by Abdelfattah Mohamed Samir Abdelrazek on Tuesday, August 15. Coombe Gary A had sold 1,675 shares worth $154,168. On Tuesday, August 15 the insider Keith R. Alexandra sold $154,168. $244,828 worth of The Procter & Gamble Company (NYSE:PG) was sold by Biegger Mark F.

Ct Mason, which manages about $311.59M and $275.34M US Long portfolio, upped its stake in Apple Inc. (NASDAQ:AAPL) by 10,518 shares to 66,556 shares, valued at $10.26M in 2017Q3, according to the filing. It also increased its holding in Bank Of America Corp. (NYSE:BAC) by 167,760 shares in the quarter, for a total of 270,690 shares, and has risen its stake in Texas Intstruments (NASDAQ:TXN).

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>